Harnessing HIV for therapy, basic research and biotechnology

Trends in Biotechnology

Volumn 23, Issue 1, 2005, Pages 42-47

  Wiznerowicz, Maciej ^a,b   Trono, Didier ^a,b  

^a SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM (CNS); HEMATOPOIETIC STEM CELLS (HSC); LENTIVIRAL VECTORS;

CELLS; DISEASE CONTROL; DNA; GENE TRANSFER; RNA; VECTORS;

BIOTECHNOLOGY;

COMPLEMENTARY DNA; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; VIRUS VECTOR;

BIOTECHNOLOGY; CENTRAL NERVOUS SYSTEM; DNA LIBRARY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL RESEARCH; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENE; VIRUS GENE; VIRUS INFECTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIV-1; HUMANS; RNA INTERFERENCE; STEM CELLS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES;

EID: 11344252479     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2004.11.001     Document Type: Review

References (61)

1. D. Trono Lentiviral Vectors 2002 Springer
2. E.M. Poeschla Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors Nat. Med. 4 1998 354 357
3. S.M. White Lentivirus vectors using human and simian immunodeficiency virus elements J. Virol. 73 1999 2832 2840
4. J.C. Olsen Gene transfer vectors derived from equine infectious anemia virus Gene Ther. 5 1998 1481 1487
5. M. Stremlau The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys Nature 427 2004 848 853
6. L. Naldini In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 272 1996 263 267
7. J.H. Kordower Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 2000 767 773
8. N.D. Mazarakis Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery Hum. Mol. Genet. 10 2001 2109 2121
9. M. Azzouz VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model Nature 429 2004 413 417
10. C. Lo Bianco α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 99 2002 10813 10818
11. E. Regulier Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum Hum. Mol. Genet. 12 2003 2827 2836
12. L.P. de Almeida Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length J. Neurosci. 22 2002 3473 3483
13. F. Moreau-Gaudry High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors Blood 98 2001 2664 2672
14. W. Chen Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice Stem Cells 18 2000 352 359
15. Y. Hanazono Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy Stem Cells 19 2001 12 23
16. P.A. Horn Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons Gene Ther. 9 2002 1464 1471
17. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors Science 283 1999 682 686
18. N.B. Woods Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells Blood 96 2000 3725 3733
19. T. Kafri Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors Nat. Genet. 17 1997 314 317
20. A. Follenzi Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice Blood 103 2004 3700 3709
21. T.H. Nguyen Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes Mol. Ther. 6 2002 199 209
22. Y. Kang In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River virus glycoproteins J. Virol. 76 2002 9378 9388
23. T. VandenDriessche Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo Blood 100 2002 813 822
24. A. Pfeifer Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging Mol. Ther. 3 2001 319 322
25. F. Park The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo Mol. Ther. 8 2003 314 323
26. F. Park Efficient lentiviral transduction of liver requires cell cycling in vivo Nat. Genet. 24 2000 49 52
27. K. Ohashi Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo Hum. Gene Ther. 13 2002 653 663
28. Y. Cui Immunotherapy of established tumors using bone marrow transplantation with antigen gene-modified hematopoietic stem cells Nat. Med. 9 2003 952 958
29. S. Hacein-Bey-Abina LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419
30. R. Zufferey Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery J. Virol. 72 1998 9873 9880
31. C. May Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin Nature 406 2000 82 86
32. R. Pawliuk Correction of sickle cell disease in transgenic mouse models by gene therapy Science 294 2001 2368 2371
33. C. Toniatti Gene therapy progress and prospects: transcription regulatory systems Gene Ther. 11 2004 649 657
34. M. Gossen, and H. Bujard Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc. Natl. Acad. Sci. U. S. A. 89 1992 5547 5551
35. M. Gossen Transcriptional activation by tetracyclines in mammalian cells Science 268 1995 1766 1769
36. S. Urlinger Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity Proc. Natl. Acad. Sci. U. S. A. 97 2000 7963 7968
37. T. Kafri Lentiviral vectors: regulated gene expression Mol. Ther. 1 2000 516 521
38. R. Vogel A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain Hum. Gene Ther. 15 2004 157 165
39. E. Vigna Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors Mol. Ther. 5 2002 252 261
40. S.M. Elbashir Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
41. T.R. Brummelkamp A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550 553
42. T. Abbas-Terki Lentiviral-mediated RNA interference Hum. Gene Ther. 13 2002 2197 2201
43. M. Wiznerowicz, and D. Trono Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference J. Virol. 77 2003 8957 8961
44. D.A. Rubinson A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference Nat. Genet. 33 2003 401 406
45. S. Gupta Inducible, reversible, and stable RNA interference in mammalian cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 1927 1932
46. S. Matsukura Establishment of conditional vectors for hairpin siRNA knockdowns Nucleic Acids Res. 31 2003 e77
47. M. Van de Wetering Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector EMBO Rep. 4 2003 609 615
48. J. Wang Stable and controllable RNA interference: investigating the physiological function of glutathionylated actin Proc. Natl. Acad. Sci. U. S. A. 100 2003 5103 5106
49. U. Deuschle Tetracycline-reversible silencing of eukaryotic promoters Mol. Cell. Biol. 15 1995 1907 1914
50. S.R. Cherry Retroviral expression in embryonic stem cells and hematopoietic stem cells Mol. Cell. Biol. 20 2000 7419 7426
51. C. Lois Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors Science 295 2002 868 872
52. A. Pfeifer Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos Proc. Natl. Acad. Sci. U. S. A. 99 2002 2140 2145
53. A. Hofmann Efficient transgenesis in farm animals by lentiviral vectors EMBO Rep. 4 2003 1054 1060
54. A. Hofmann Generation of transgenic cattle by lentiviral gene transfer into oocytes Biol. Reprod. 71 2004 405 409
55. M.J. Wolfgang Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos Proc. Natl. Acad. Sci. U. S. A. 98 2001 10728 10732
56. F.K. Hamra Production of transgenic rats by lentiviral transduction of male germ-line stem cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 14931 14936
57. A. Ventura Cre-lox-regulated conditional RNA interference from transgenes Proc. Natl. Acad. Sci. U. S. A. 101 2004 10380 10385
58. G. Tiscornia CRE recombinase-inducible RNA interference mediated by lentiviral vectors Proc. Natl. Acad. Sci. U. S. A. 101 2004 7347 7351
59. P. Escarpe Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations Mol. Ther. 8 2003 332 341
60. X. Lu Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance J. Virol. 78 2004 7079 7088
61. F.D. Bushman Integration site selection by lentiviruses: biology and possible control Curr. Top. Microbiol. Immunol. 261 2002 165 177